De Luca S, Verdoliva V, Saviano M
Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives
J Med Chem (ISSN: 0022-2623linking, 0022-2623print, 1520-4804), 2020 Dec 24; 63(24): 15333-15343.

De Luca S, Verdoliva V, Saviano M, Fattorusso R, Diana D
SPR and NMR characterization of the molecular interaction between A9 peptide and a model system of HER2 receptor: A fragment approach for selecting peptide structures specific for their target
J Pept Sci (ISSN: 1075-2617linking, 1099-1387electronic), 2020 Feb; 26(2): e3231-e3231.

Langella E, Calce E, Saviano M, De Luca S
Structural identification of an HER2 receptor model binding pocket to optimize lead compounds: a combined experimental and computational approach
Mol Biosyst (ISSN: 1742-206x), 2016 Jun 21; 12(7): 2159-2167.

Calce E, Saviano M, De Luca S
Development of Targeting Ligands for HER2 Receptor: Simplified Receptor Model Employed for Selecting Highly Specific Molecules
International Journal Of Peptide Research And Therapeutics, 2016; 22(2): 237-242.

Calce E, Monfregola L, Saviano M, De Luca S
HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2015 May 20; 22(21): 2525-2538.

Calce E, Sandomenico A, Saviano M, Ruvo M, De Luca S
Cysteine Co-Oxidation Process Driven By Native Peptide Folding: An Example On Her2 Receptor Model System
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2014; 46(5): 1197-1206.

Avitabile C, Moggio L, Malgieri G, Capasso D, Di Gaetano S, Saviano M, Pedone C, Romanelli A
Gamma Sulphate Pna (pna S): Highly Selective Dna Binding Molecule Showing Promising Antigene Activity
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2012 May 7; 7(5): e35774-e35774.

Folgiero V, Di Carlo SE, Bossi G, Spugnini E, Di Benedetto A, Bon G, Milella M, Fabi A, Accardo A, Morelli G, Mottolese M, Falcioni R
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2012; 3(12): N/D-N/D.

Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
A novel ErbB2 epitope targeted by human antitumor immunoagents
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.

Monfregola L, Vitale RM, Amodeo P, De Luca S
A SPR strategy for high-throughput ligand screenings based on synthetic peptides mimicking a selected subdomain of the target protein: A proof of concept on HER2 receptor
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 1464-3391electronic), 2009 Oct 1; 17(19): 7015-7020.

Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, De Mauro G, Cerchia L, Riccio P, Baumhoer D, Condorelli G, Terracciano L, De Franciscis V
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors
Oncology (ISSN: 0030-2414), 2009; 77(6): 378-384.

De Luca S, Sanseverino M, Zocchi I, Pedone C, Morelli G, Ragone R
Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: A fluorescence study on type B receptor fragment CCKB-R (352-379)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2005 Mar; 77(4): 205-211.